Home › Ischemic Stroke › Tennessee › Chattanooga
Ischemic Stroke clinical trials in Chattanooga, TN
4 studies for Ischemic Stroke are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
RecruitingPhase 3
- CHI Memorial Neuroscience Institute, Chattanooga
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RecruitingPhase 2/3
- Corxel Investigational Site, Chattanooga
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RecruitingPhase 2/3
- Erlanger Hospital, Chattanooga
- Chattanooga Center for Neurologic Research, Chattanooga
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Recruiting
- Erlanger Medical Center, Chattanooga
About Ischemic Stroke
A stroke is a medical emergency that should be treated immediately. Read about the causes, symptoms and treatments for an ischemic stroke.
More about Ischemic Stroke on MedlinePlus
Ischemic Stroke trials in other cities
- New York City, NY18 studies
- Houston, TX17 studies
- Boston, MA16 studies
- Los Angeles, CA14 studies
- Atlanta, GA13 studies
- St. Louis, MO12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Cincinnati, OH12 studies
- Pittsburgh, PA11 studies
- Salt Lake City, UT10 studies
- New Haven, CT10 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer9 studies
- Myasthenia Gravis5 studies
- Metastatic Cancer5 studies
- Steatotic Liver Disease4 studies
- COPD4 studies
- Ovarian Cancer4 studies
- Melanoma4 studies
- Lung Cancer4 studies
- Stroke3 studies
- Diabetes3 studies
- Colorectal Cancer3 studies
- High Blood Pressure3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.